Literature DB >> 18502339

External beam radiation therapy for thyroid cancer.

James D Brierley1, Richard W Tsang.   

Abstract

This article discusses the role of external beam radiotherapy (XRT) in the management of well-differentiated thyroid cancer (WDTC), medullary thyroid cancer, and anaplastic thyroid cancer. Although there are no randomized controlled studies on the use of XRT in thyroid cancer, evidence supports its use to treat gross disease after surgery or unresectable cancer and its use as an adjuvant after resection of a known high-risk disease in WDTC, and, to a lesser extent, in medullary thyroid cancer. The use of XRT for the palliation of symptomatic disease and recent advances in the technology of radiation delivery also will be discussed.

Entities:  

Mesh：

Year:  2008        PMID： 18502339     DOI： 10.1016/j.ecl.2008.02.001

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  16 in total

Review 1.  Surgical management of medullary thyroid carcinoma.

Authors:  Agathoklis Konstantinidis; Michael Stang; Sanziana A Roman; Julie Ann Sosa
Journal:  Updates Surg       Date:  2017-04-13

2.  Mass in the neck after radiation exposure from Chernobyl disaster.

Authors:  John C O'Brien; S Michelle Shiller; Matthew G Cusick; Baron L Hamman
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-04

3.  Current concepts and future directions in differentiated thyroid cancer.

Authors:  Donald S A McLeod
Journal:  Clin Biochem Rev       Date:  2010-02

Review 4.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

5.  Adjuvant External Beam Radiotherapy in Locally Advanced Differentiated Thyroid Cancer.

Authors:  Samantha Tam; Moran Amit; Mongkol Boonsripitayanon; Maria E Cabanillas; Naifa L Busaidy; G Brandon Gunn; Stephen Y Lai; Neil D Gross; Erich M Sturgis; Mark E Zafereo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-12-01       Impact factor: 6.223

Review 6.  Standard and emerging therapies for metastatic differentiated thyroid cancer.

Authors:  Christine J O'Neill; Jennifer Oucharek; Diana Learoyd; Stan B Sidhu
Journal:  Oncologist       Date:  2010-02-08

Review 7.  Optimizing therapy for radioactive iodine-refractory differentiated thyroid cancer: current state of the art and future directions.

Authors:  R Dadu; M E Cabanillas
Journal:  Minerva Endocrinol       Date:  2012-12       Impact factor: 2.184

8.  2012 European thyroid association guidelines for metastatic medullary thyroid cancer.

Authors:  M Schlumberger; L Bastholt; H Dralle; B Jarzab; F Pacini; J W A Smit
Journal:  Eur Thyroid J       Date:  2012-03-28

9.  Diagnostic 131I whole-body scintigraphy 1 year after thyroablative therapy in patients with differentiated thyroid cancer: correlation of results to the individual risk profile and long-term follow-up.

Authors:  Frank Berger; Ulla Friedrich; Peter Knesewitsch; Klaus Hahn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-18       Impact factor: 9.236

10.  Extensive papillary carcinoma of the thyroid gland treated by external beam radiotherapy, surgery and postoperative radioactive iodine therapy.

Authors:  Anjum Naveed; F Kanaan; N O Tjernstrom
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-18       Impact factor: 2.503
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.